Next Article in Journal
Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors
Previous Article in Journal
Analysis of the Fungal Community in Ziziphi Spinosae Semen through High-Throughput Sequencing
Previous Article in Special Issue
A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes

Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine

Department of Anesthesia and Perioperative Care, University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, Room 3C-38, 1001 Potrero Avenue, San Francisco, CA 94110, USA
Authors to whom correspondence should be addressed.
Toxins 2018, 10(12), 495;
Received: 20 November 2018 / Accepted: 22 November 2018 / Published: 26 November 2018
(This article belongs to the Special Issue Botulinum Neurotoxins Antibody and Vaccine)
Note: In lieu of an abstract, this is an excerpt from the first page.

Botulism, caused by exposure to one or more of the eight serotypes of botulinum neurotoxins (BoNTs) (BoNT/A through H), is often fatal without rapid treatment. [...] View Full-Text
MDPI and ACS Style

Lou, J.; Marks, J.D. Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine. Toxins 2018, 10, 495.

AMA Style

Lou J, Marks JD. Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine. Toxins. 2018; 10(12):495.

Chicago/Turabian Style

Lou, Jianlong, and James D. Marks. 2018. "Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine" Toxins 10, no. 12: 495.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop